Arcturus Therapeutics Ltd. Financing Cash Flow
Arcturus Therapeutics Ltd. reported Financing Cash Flow of $10.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2019-05-13
- Arcturus Therapeutics Ltd. net cash provided by (used in) financing activities for the quarter ending 2018-12-31 was $9.87M, a 834.85% increase year-over-year.
- Arcturus Therapeutics Ltd. net cash provided by (used in) financing activities for the quarter ending 2018-09-30 was -$19.00K, a 104.19% decline year-over-year.
- Arcturus Therapeutics Ltd. net cash provided by (used in) financing activities for the quarter ending 2018-06-30 was $57.00K.
- Arcturus Therapeutics Ltd. net cash provided by (used in) financing activities for the quarter ending 2018-03-31 was $294.00K.
- Arcturus Therapeutics Ltd. net cash provided by (used in) financing activities for fiscal 2018 was $10.20M, a 45.81% increase from fiscal 2017.
- Arcturus Therapeutics Ltd. net cash provided by (used in) financing activities for fiscal 2017 was $7.00M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 71 month |
|---|---|---|---|---|---|
| 2018-12-31 | $9.87M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $9.85M derived: sum of 2 quarters · filed 2019-03-18 | $9.91M derived: sum of 3 quarters · filed 2019-03-18 | $10.20M 10-K · filed 2019-03-18 | |
| 2018-09-30 | -$19.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $38.00K derived: sum of 2 quarters · filed 2018-11-07 | $332.00K 6-K · filed 2018-11-07 | $1.39M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-06-30 | $57.00K derived: 6-K 6 month − 10-Q 3 month · filed 2018-09-28 | $351.00K 6-K · filed 2018-09-28 | $1.41M derived: sum of 3 quarters · filed 2019-05-13 | $1.86M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2018-03-31 | $294.00K 10-Q · filed 2019-05-13 | $1.35M derived: sum of 2 quarters · filed 2019-05-13 | $1.80M derived: sum of 3 quarters · filed 2019-05-13 | ||
| 2017-12-31 | $1.06M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $1.51M derived: sum of 2 quarters · filed 2019-03-18 | $7.00M 10-K · filed 2019-03-18 | ||
| 2017-09-30 | $453.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $5.94M 6-K · filed 2018-11-07 | |||
| 2017-06-30 | $5.49M 6-K · filed 2018-09-28 | ||||
| 2016-12-31 | $6.00K 20-F · filed 2017-04-28 | ||||
| 2015-12-31 | $66.47M 20-F · filed 2017-04-28 | ||||
| 2014-12-31 | $0.00 20-F · filed 2017-04-28 | ||||
| 2013-12-31 | $57.40M 20-F · filed 2016-03-04 | $63.16M 20-F · filed 2014-03-28 | |||
| 2012-12-31 | $601.00K 20-F · filed 2015-02-27 | ||||
| 2011-12-31 | $2.62M 20-F · filed 2014-03-28 |